You just read:

Morphotek Announces Publication Uncovering One Of The Mechanisms By Which The Tumor-Produced CA125 Protein Suppresses Immune-Mediated Killing Via Farletuzumab

News provided by

Morphotek, Inc.

Jul 11, 2017, 10:00 ET